IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v620y2023i7976d10.1038_s41586-023-06370-4.html
   My bibliography  Save this article

Africa-specific human genetic variation near CHD1L associates with HIV-1 load

Author

Listed:
  • Paul J. McLaren

    (Public Health Agency of Canada
    University of Manitoba)

  • Immacolata Porreca

    (Wellcome Trust Sanger Institute)

  • Gennaro Iaconis

    (University of Cambridge)

  • Hoi Ping Mok

    (University of Cambridge)

  • Subhankar Mukhopadhyay

    (King’s College London)

  • Emre Karakoc

    (Wellcome Trust Sanger Institute)

  • Sara Cristinelli

    (Lausanne University Hospital and University of Lausanne)

  • Cristina Pomilla

    (Wellcome Trust Sanger Institute)

  • István Bartha

    (École Polytechnique Fédérale de Lausanne
    Swiss Institute of Bioinformatics)

  • Christian W. Thorball

    (École Polytechnique Fédérale de Lausanne
    Swiss Institute of Bioinformatics
    Lausanne University Hospital (CHUV) and University of Lausanne)

  • Riley H. Tough

    (Public Health Agency of Canada
    University of Manitoba)

  • Paolo Angelino

    (Swiss Institute of Bioinformatics)

  • Cher S. Kiar

    (King’s College London)

  • Tommy Carstensen

    (Wellcome Trust Sanger Institute
    University of Cambridge)

  • Segun Fatumo

    (MRC/UVRI and LSHTM Uganda Research Unit
    London School of Hygiene and Tropical Medicine)

  • Tarryn Porter

    (Wellcome Trust Sanger Institute)

  • Isobel Jarvis

    (University of Cambridge)

  • William C. Skarnes

    (The Jackson Laboratory for Genomic Medicine)

  • Andrew Bassett

    (Wellcome Trust Sanger Institute)

  • Marianne K. DeGorter

    (Stanford University School of Medicine)

  • Mohana Prasad Sathya Moorthy

    (Stanford University School of Medicine
    Stanford University School of Medicine)

  • Jeffrey F. Tuff

    (Public Health Agency of Canada)

  • Eun-Young Kim

    (Northwestern University)

  • Miriam Walter

    (Northwestern University)

  • Lacy M. Simons

    (Northwestern University)

  • Arman Bashirova

    (National Cancer Institute
    National Cancer Institute)

  • Susan Buchbinder

    (San Francisco Department of Public Health)

  • Mary Carrington

    (National Cancer Institute
    National Cancer Institute
    MIT and Harvard)

  • Andrea Cossarizza

    (University of Modena and Reggio Emilia)

  • Andrea Luca

    (Siena University Hospital
    University of Siena)

  • James J. Goedert

    (National Cancer Institute, National Institutes of Health)

  • David B. Goldstein

    (Columbia University)

  • David W. Haas

    (Vanderbilt University School of Medicine)

  • Joshua T. Herbeck

    (University of Washington)

  • Eric O. Johnson

    (RTI International)

  • Pontiano Kaleebu

    (Medical Research Council/Uganda Virus Research Institute & London School of Hygiene and Tropical Medicine, Uganda Research Unit
    London School of Hygiene and Tropical Medicine)

  • William Kilembe

    (Center for Family Health Research—Zambia)

  • Gregory D. Kirk

    (Johns Hopkins University)

  • Neeltje A. Kootstra

    (University of Amsterdam)

  • Alex H. Kral

    (RTI International)

  • Olivier Lambotte

    (Université Paris Saclay, Inserm UMR1184, CEA
    Bicêtre Hospital)

  • Ma Luo

    (University of Manitoba
    Public Health Agency of Canada)

  • Simon Mallal

    (Vanderbilt University School of Medicine
    Murdoch University)

  • Javier Martinez-Picado

    (University of Vic—Central University of Catalonia
    IrsiCaixa AIDS Research Institute
    Catalan Institution for Research and Advanced Studies
    CIBERINFEC, Instituto de Salud Carlos III)

  • Laurence Meyer

    (INSERM U1018, Université Paris-Saclay
    AP-HP, Hôpital de Bicêtre, Département d’Épidémiologie)

  • José M. Miro

    (CIBERINFEC, Instituto de Salud Carlos III
    Infectious Diseases Service, Hospital Clinic—Institut d’Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona)

  • Pravi Moodley

    (South Africa and University of KwaZulu-Natal)

  • Ayesha A. Motala

    (University of KwaZulu-Natal)

  • James I. Mullins

    (University of Washington)

  • Kireem Nam

    (Northwestern University)

  • Niels Obel

    (Copenhagen University Hospital, Rigshospitalet)

  • Fraser Pirie

    (University of KwaZulu-Natal)

  • Francis A. Plummer

    (University of Manitoba)

  • Guido Poli

    (San Raffaele Scientific Institute
    Vita-Salute San Raffaele University)

  • Matthew A. Price

    (International AIDS Vaccine Initiative
    University of California)

  • Andri Rauch

    (Bern University Hospital, University of Bern)

  • Ioannis Theodorou

    (Hôpital Robert Debré Paris)

  • Alexandra Trkola

    (University of Zurich)

  • Bruce D. Walker

    (MIT and Harvard
    Howard Hughes Medical Institute)

  • Cheryl A. Winkler

    (National Cancer Institute)

  • Jean-François Zagury

    (EA7528, Conservatoire National des Arts et Métiers, HESAM Université)

  • Stephen B. Montgomery

    (Stanford University School of Medicine
    Stanford University School of Medicine)

  • Angela Ciuffi

    (Lausanne University Hospital and University of Lausanne)

  • Judd F. Hultquist

    (Northwestern University)

  • Steven M. Wolinsky

    (Northwestern University)

  • Gordon Dougan

    (Wellcome Trust Sanger Institute
    University of Cambridge)

  • Andrew M. L. Lever

    (University of Cambridge
    National University of Singapore)

  • Deepti Gurdasani

    (Queen Mary University of London
    University of New South Wales)

  • Harriet Groom

    (University of Cambridge)

  • Manjinder S. Sandhu

    (Imperial College London
    Imperial College London
    Omnigen Biodata)

  • Jacques Fellay

    (École Polytechnique Fédérale de Lausanne
    Swiss Institute of Bioinformatics
    Lausanne University Hospital (CHUV) and University of Lausanne)

Abstract

HIV-1 remains a global health crisis1, highlighting the need to identify new targets for therapies. Here, given the disproportionate HIV-1 burden and marked human genome diversity in Africa2, we assessed the genetic determinants of control of set-point viral load in 3,879 people of African ancestries living with HIV-1 participating in the international collaboration for the genomics of HIV3. We identify a previously undescribed association signal on chromosome 1 where the peak variant associates with an approximately 0.3 log10-transformed copies per ml lower set-point viral load per minor allele copy and is specific to populations of African descent. The top associated variant is intergenic and lies between a long intergenic non-coding RNA (LINC00624) and the coding gene CHD1L, which encodes a helicase that is involved in DNA repair4. Infection assays in iPS cell-derived macrophages and other immortalized cell lines showed increased HIV-1 replication in CHD1L-knockdown and CHD1L-knockout cells. We provide evidence from population genetic studies that Africa-specific genetic variation near CHD1L associates with HIV replication in vivo. Although experimental studies suggest that CHD1L is able to limit HIV infection in some cell types in vitro, further investigation is required to understand the mechanisms underlying our observations, including any potential indirect effects of CHD1L on HIV spread in vivo that our cell-based assays cannot recapitulate.

Suggested Citation

  • Paul J. McLaren & Immacolata Porreca & Gennaro Iaconis & Hoi Ping Mok & Subhankar Mukhopadhyay & Emre Karakoc & Sara Cristinelli & Cristina Pomilla & István Bartha & Christian W. Thorball & Riley H. T, 2023. "Africa-specific human genetic variation near CHD1L associates with HIV-1 load," Nature, Nature, vol. 620(7976), pages 1025-1030, August.
  • Handle: RePEc:nat:nature:v:620:y:2023:i:7976:d:10.1038_s41586-023-06370-4
    DOI: 10.1038/s41586-023-06370-4
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41586-023-06370-4
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1038/s41586-023-06370-4?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:620:y:2023:i:7976:d:10.1038_s41586-023-06370-4. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.